AUPH
AuriniaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
AUPH vs peer average
55/100
AUPH vs. peer average (C vs. C)
Grade spread
B 2 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Gilead is a useful commercial-biopharma comp for specialty-drug execution and capital allocation, but it is not a direct lupus nephritis peer, so read-through is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AUPH
Aurinia
GILD
Gilead Sciences
Grade
C
C
Momentum
27
28
Value
66
65
Sentiment
55
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs GILD
AUPH / GILD
Grade Position
In line
AUPH vs. peer average (C vs. C)
55/100
Momentum
27
GILDValue
66
AUPHSentiment
55
GILDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AUPH
GILD is the first peer returned for this comparison set.

